J Neurol Neurosurg Psychiatry 83:474 doi:10.1136/jnnp-2012-302477
  • Editorial commentary

Early recognition of POEMS syndrome: what is the role of clinical neurophysiology?

  1. Kimiyoshi Arimura
  1. Okatsu Neurology and Rehabilitation Hospital, 3-95 Masagohonpachi, Kagoshima, Japan
  1. Correspondence to Dr Kimiyoshi Arimura, Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medicine, 8351 Sakuragaoka, Kagoshima 9.80852e+006, Japan; ari{at}
  1. Contributors KA is the sole contributor to this commentary.

  • Received 9 February 2012
  • Revised 17 February 2012
  • Accepted 18 February 2012

POEMS syndrome (also known as Crow–Fukase syndrome) is a serious systemic disease characterised by polyneuropathy, anasarca, skin lesions and associated with ostoclastic bone lesions and with M-proteinemia. The diagnosis of POEMS syndrome is made robust by finding increased serum/plasma vascular endothelial growth factor (VEGF) in addition to the combination of the above mentioned characteristic manifestations.1 In fact, the recognition of POEMS syndrome has been enunciated by recent diagnostic guidelines from the western and Asian countries. From our end, a second nationwide survey of POEMS syndrome was conducted in Japan in 2004. The estimated number of affected individuals all over Japan was calculated …

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article